WO2004007483A1 - Neue makrocyclen zur behandlung von krebserkrankungen - Google Patents
Neue makrocyclen zur behandlung von krebserkrankungen Download PDFInfo
- Publication number
- WO2004007483A1 WO2004007483A1 PCT/EP2003/007663 EP0307663W WO2004007483A1 WO 2004007483 A1 WO2004007483 A1 WO 2004007483A1 EP 0307663 W EP0307663 W EP 0307663W WO 2004007483 A1 WO2004007483 A1 WO 2004007483A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- groups
- formula
- compounds
- alkyl
- Prior art date
Links
- 0 CC(C*)CCCC(C)=CCC(*)(C(C)=CC1(C)N=C(C)SC1)O Chemical compound CC(C*)CCCC(C)=CCC(*)(C(C)=CC1(C)N=C(C)SC1)O 0.000 description 3
- IFYQDOJVTSAXKO-ADHCAXNZSA-N CC(CCC/C(/C)=C\CC(/C(/C)=C/c1c[s]c(C)n1)O)COSC=C Chemical compound CC(CCC/C(/C)=C\CC(/C(/C)=C/c1c[s]c(C)n1)O)COSC=C IFYQDOJVTSAXKO-ADHCAXNZSA-N 0.000 description 1
- TZJFCYRTGADQOR-GTQCXRAXSA-N CC(CCC/C(/C)=C\CCC(C)(C)[C@H]1SC(C)N(C)C1)C=O Chemical compound CC(CCC/C(/C)=C\CCC(C)(C)[C@H]1SC(C)N(C)C1)C=O TZJFCYRTGADQOR-GTQCXRAXSA-N 0.000 description 1
- BQMHWQPMCRTJKI-UHFFFAOYSA-N CC(N(C)C)SC=C Chemical compound CC(N(C)C)SC=C BQMHWQPMCRTJKI-UHFFFAOYSA-N 0.000 description 1
- KZIAVMXNUIOLMS-HJWRWDBZSA-N CCC(C)/N=C(/C)\SC=C Chemical compound CCC(C)/N=C(/C)\SC=C KZIAVMXNUIOLMS-HJWRWDBZSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D315/00—Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/520,766 US20060122241A1 (en) | 2002-07-15 | 2003-07-15 | Novel macrocycles for the treatment of cancer diseases |
CA002491422A CA2491422A1 (en) | 2002-07-15 | 2003-07-15 | Novel macrocycles for the treatment of cancer diseases |
AU2003250957A AU2003250957A1 (en) | 2002-07-15 | 2003-07-15 | Novel macrocycles for the treatment of cancer diseases |
EP03763869A EP1521750A1 (de) | 2002-07-15 | 2003-07-15 | Neue makrocyclen zur behandlung von krebserkrankungen |
JP2004520646A JP2005535669A (ja) | 2002-07-15 | 2003-07-15 | がん疾病治療用新規マクロ環 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10232094A DE10232094A1 (de) | 2002-07-15 | 2002-07-15 | 5-Thiaepothilone und 15-disubstituierte Epothilone |
DE10232094.2 | 2002-07-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004007483A1 true WO2004007483A1 (de) | 2004-01-22 |
Family
ID=30010025
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/006066 WO2004007476A1 (en) | 2002-07-15 | 2003-06-10 | Gesellschaft für biotechnologische forschung mbh (gbf) |
PCT/EP2003/007663 WO2004007483A1 (de) | 2002-07-15 | 2003-07-15 | Neue makrocyclen zur behandlung von krebserkrankungen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/006066 WO2004007476A1 (en) | 2002-07-15 | 2003-06-10 | Gesellschaft für biotechnologische forschung mbh (gbf) |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060122241A1 (de) |
EP (1) | EP1521750A1 (de) |
JP (1) | JP2005535669A (de) |
AR (1) | AR040573A1 (de) |
AU (2) | AU2003246409A1 (de) |
CA (1) | CA2491422A1 (de) |
DE (1) | DE10232094A1 (de) |
TW (1) | TW200410964A (de) |
WO (2) | WO2004007476A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8129561B2 (en) | 2003-06-18 | 2012-03-06 | Tranzyme Pharma Inc. | Processes for intermediates for macrocyclic compounds |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
JP4791183B2 (ja) | 2002-08-23 | 2011-10-12 | スローン−ケッタリング インスティトュート フォア キャンサー リサーチ | エポチロン、その中間体、類似体の合成およびその使用 |
WO2004048372A1 (en) * | 2002-11-28 | 2004-06-10 | Morphochem Ag Komb Chemie | Thia-epothilone derivatives for the treatment of cancer |
AU2011255647A1 (en) | 2010-05-18 | 2012-11-15 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999002514A2 (en) * | 1997-07-08 | 1999-01-21 | Bristol-Myers Squibb Company | Epothilone derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997019086A1 (de) * | 1995-11-17 | 1997-05-29 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Epothilonderivate, herstellung und verwendung |
-
2002
- 2002-07-15 DE DE10232094A patent/DE10232094A1/de not_active Withdrawn
-
2003
- 2003-06-10 WO PCT/EP2003/006066 patent/WO2004007476A1/en not_active Application Discontinuation
- 2003-06-10 AU AU2003246409A patent/AU2003246409A1/en not_active Abandoned
- 2003-07-14 TW TW092119094A patent/TW200410964A/zh unknown
- 2003-07-15 WO PCT/EP2003/007663 patent/WO2004007483A1/de active Application Filing
- 2003-07-15 EP EP03763869A patent/EP1521750A1/de not_active Withdrawn
- 2003-07-15 JP JP2004520646A patent/JP2005535669A/ja not_active Withdrawn
- 2003-07-15 AR AR20030102541A patent/AR040573A1/es unknown
- 2003-07-15 CA CA002491422A patent/CA2491422A1/en not_active Abandoned
- 2003-07-15 US US10/520,766 patent/US20060122241A1/en not_active Abandoned
- 2003-07-15 AU AU2003250957A patent/AU2003250957A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999002514A2 (en) * | 1997-07-08 | 1999-01-21 | Bristol-Myers Squibb Company | Epothilone derivatives |
Non-Patent Citations (1)
Title |
---|
NICOLAOU,K C: "CHEMICAL BIOLOGY OF EPOTHILONES", ANGEWANDTE CHEMIE. INTERNATIONAL EDITION., vol. 37, no. 15, August 1998 (1998-08-01), VERLAG CHEMIE. WEINHEIM., DE, pages 2021 - 42, XP002131418, ISSN: 0570-0833 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8129561B2 (en) | 2003-06-18 | 2012-03-06 | Tranzyme Pharma Inc. | Processes for intermediates for macrocyclic compounds |
US8497242B2 (en) | 2003-06-18 | 2013-07-30 | Tranzyme Pharma Inc. | Processes for intermediates for macrocyclic compounds |
US9181298B2 (en) | 2003-06-18 | 2015-11-10 | Ocera Therapeutics, Inc. | Intermediates for macrocyclic compounds |
US10040751B2 (en) | 2003-06-18 | 2018-08-07 | Ocera Therapeutics, Inc. | Intermediates for macrocyclic compounds |
Also Published As
Publication number | Publication date |
---|---|
DE10232094A1 (de) | 2004-02-05 |
AU2003246409A1 (en) | 2004-02-02 |
CA2491422A1 (en) | 2004-01-22 |
AR040573A1 (es) | 2005-04-13 |
EP1521750A1 (de) | 2005-04-13 |
AU2003250957A1 (en) | 2004-02-02 |
TW200410964A (en) | 2004-07-01 |
JP2005535669A (ja) | 2005-11-24 |
US20060122241A1 (en) | 2006-06-08 |
WO2004007476A1 (en) | 2004-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1521769B1 (de) | Tubulysinkonjugate | |
DE102005019181A1 (de) | Peptid-Deformylase (PDF) Inhibitoren 1 | |
EP1523493B1 (de) | Neue tubulysinanaloga | |
DE102005017116A1 (de) | Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP) | |
DE102004041163A1 (de) | Neue Verbindungen mit antibakterieller Aktivität | |
DE10316081A1 (de) | Neue Verbindungen mit antibakterieller Aktivität | |
DE60220778T2 (de) | 3,4-disubstituierte cyclobuten-1,2-dione als cxc-chemokinrezeptorliganden | |
DE60319714T2 (de) | Agonisten des cannabinoidrezeptors | |
WO2004005269A1 (de) | Verfahren zur herstellung von substituierten thiazol-2-ylmethylestern | |
DE10320453A1 (de) | Neue Bioisostere von Actinonin | |
EP1521750A1 (de) | Neue makrocyclen zur behandlung von krebserkrankungen | |
EP1581165B1 (de) | Verbindungen, die faktor viia inhibieren | |
EP1893574A2 (de) | Peptiddeformylase- (pdf-) inhibitoren 4 | |
DE102005026231A1 (de) | Peptid-Deformylase (PDF) Inhibitoren 3 | |
DE10327472A1 (de) | Neue Makrocyclen zur Behandlung von Krebserkrankungen | |
DE10256976A1 (de) | Hydroxamsäuren als Methionin-Aminopeptidase (MAP) Inhibitoren | |
DE10247233A1 (de) | Neue Verbindungen, die Topoisomerase IV inhibieren | |
DE60124397T2 (de) | Inhibitoren von serinproteasen | |
DE10342292A1 (de) | Neue Makrolid Antibiotika | |
DE10230874A1 (de) | Neue Tubulysinanaloga | |
DE102007013812A1 (de) | Neue Inhibitoren van Aspartylproteasen | |
DE10355223A1 (de) | Neue Makrocyclen zur Behandlung von Krebserkrankungen | |
EP1689745B1 (de) | Neue makrocyclen zur behandlung von krebserkrankungen | |
DE102006028649A1 (de) | Neue Verbindungen mit antibakterieller Aktivität | |
DE102006062278A1 (de) | Neues Verfahren zur stereoselektiven Herstellung von 2.4-disubstiluierten γ-Aminosäuren und deren Nutzung in der Totalsynthese von cytotoxischen Substanzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2491422 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004520646 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003763869 Country of ref document: EP Ref document number: 2003250957 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2003763869 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006122241 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10520766 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10520766 Country of ref document: US |